FDA Inspection 1219451 — Institute for Reproductive Medicine and Science at Saint Barnabas, P.A.
The FDA completed an inspection of Institute for Reproductive Medicine and Science at Saint Barnabas, P.A. on September 27, 2023 in Livingston, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 27, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Livingston, NJ (United States)